Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
Status:
Recruiting
Trial end date:
2031-02-20
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare in resectable liver metastases colorectal
cancer patients.The main question it aims to answer is to investigate whether the
progression-free survival (PFS) of resectable colorectal liver metastasis (CRLM) patients
with positive ctDNA after surgery is superior with the combination of adjuvant chemotherapy
and maintenance therapy compared to adjuvant chemotherapy alone.